Literature DB >> 15024583

Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.

Takashi Togo1, Haruhiko Akiyama, Eizo Iseki, Hirotake Uchikado, Hiromi Kondo, Kenji Ikeda, Kuniaki Tsuchiya, Rohan de Silva, Andrew Lees, Kenji Kosaka.   

Abstract

Accumulation of abnormally phosphorylated tau results in the formation of neurofibrillary tangles (NFTs) in the neuronal cell soma and neuropil threads (NTs) in the cell processes. In the present study, we used immunohistochemistry to investigate serially cut thick tissue sections from the brains of patients with Alzheimer's disease (AD) and non-demented elderly subjects. In the early stages of neurofibrillary pathology, clusters of NTs occurred occasionally in the cerebral cortex. Each NTs cluster, the entire extent of which was observed in the serial sections, corresponded to a dendritic tree that was arborized from a tau-positive neuron. Adult human brain contains six tau isoforms with three having three carboxyl-terminal tandem repeat sequences that are encoded by exon 10 (3R-tau) and the other three having four repeat sequences (4R-tau). Three isoform patterns, 3R-tau(+)/4R-tau(-), 3R-tau(-)/4R-tau(+) and 3R-tau(+)/4R-tau(+), were seen in NFTs in early stage AD lesions. In an individual neuron, the isoform pattern was consistent between the NFTs in the cell soma and the NTs in the cell processes. The results of this study indicate that, in early stages of AD and age-associated neurofibrillary changes, tau accumulates simultaneously in the cell soma and cell processes of affected neurons. The process of AD and age-associated tau pathology is not tau-isoform-specific, but the ratio of 3R-tau and 4R-tau isoforms involved in the neurofibrillary changes varies and is specific to individual neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024583     DOI: 10.1007/s00401-004-0842-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

Review 1.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

Review 2.  Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.

Authors:  P Hemachandra Reddy
Journal:  Brain Res       Date:  2011-07-31       Impact factor: 3.252

Review 3.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

4.  Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer's disease.

Authors:  Jonathan D Cherry; Camille D Esnault; Zachary H Baucom; Yorghos Tripodis; Bertrand R Huber; Victor E Alvarez; Thor D Stein; Dennis W Dickson; Ann C McKee
Journal:  Acta Neuropathol Commun       Date:  2021-05-12       Impact factor: 7.578

5.  Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain.

Authors:  Ayaho Dan; Muneaki Takahashi; Masami Masuda-Suzukake; Fuyuki Kametani; Takashi Nonaka; Hiromi Kondo; Haruhiko Akiyama; Takao Arai; David M A Mann; Yuko Saito; Hiroyuki Hatsuta; Shigeo Murayama; Masato Hasegawa
Journal:  Acta Neuropathol Commun       Date:  2013-08-21       Impact factor: 7.801

6.  Hypoxia alters expression of zebrafish microtubule-associated protein tau (mapta, maptb) gene transcripts.

Authors:  Seyyed Hani Moussavi Nik; Morgan Newman; Swamynathan Ganesan; Mengqi Chen; Ralph Martins; Giuseppe Verdile; Michael Lardelli
Journal:  BMC Res Notes       Date:  2014-10-31

7.  How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.

Authors:  Momoko Ebashi; Yoshinori Ito; Miho Uematsu; Ayako Nakamura; Katsuiku Hirokawa; Satoshi Kamei; Toshiki Uchihara
Journal:  Acta Neuropathol Commun       Date:  2019-05-06       Impact factor: 7.801

8.  The role of tau in neurodegeneration.

Authors:  Tania F Gendron; Leonard Petrucelli
Journal:  Mol Neurodegener       Date:  2009-03-11       Impact factor: 14.195

9.  Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation.

Authors:  Matthew R Barron; Jane Gartlon; Lee A Dawson; Peter J Atkinson; Marie-Christine Pardon
Journal:  Front Immunol       Date:  2020-03-05       Impact factor: 7.561

Review 10.  Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.

Authors:  Christina M Moloney; Val J Lowe; Melissa E Murray
Journal:  Alzheimers Dement       Date:  2021-04-02       Impact factor: 21.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.